Pure Global

Lutonix 014 Drug Coated Balloon PTA Catheter Model 9005 - Peripheral angioplasty balloon catheter, drug-eluting - ARTG 432273

Access comprehensive regulatory information for Lutonix 014 Drug Coated Balloon PTA Catheter Model 9005 - Peripheral angioplasty balloon catheter, drug-eluting in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 432273 and sponsored by Bard Australia Pty Ltd, manufactured by Bard Peripheral Vascular Inc in United States of America. The device registration started on January 03, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 432273
Class III
Lutonix 014 Drug Coated Balloon PTA Catheter Model 9005 - Peripheral angioplasty balloon catheter, drug-eluting
ARTG ID: 432273
Good Name: Bard Australia Pty Ltd - Lutonix 014 Drug Coated Balloon PTA Catheter Model 9005 - Peripheral angioplasty balloon catheter, drug-eluting
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The Lutonixโ„ข 014 Drug Coated Balloon Catheter is intended for use as a PTA catheter to dilate stenotic or obstructive vascular lesions in the popliteal and infra-popliteal arteries, for the purpose of improving limb perfusion and decreasing the incidence of restenosis.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
432273
Start Date
January 03, 2024
Effective Date
January 03, 2024
Manufacturer
Country
United States of America
Address
1625 West 3rd Street, Tempe, AZ, 85281